Search results
7 results found Showing page 1 of 1
Refine Search
Article Categories
Strategy Tags
- Direct lending (2)
- High yield bonds (5)
- Investment grade credit (3)
- Structured credit (1)
- CLO (remove)
- Leveraged loans (4)
- Synthetic/SRT (3)
- ABL Financing (1)
Geography Tags
-
Franklin Templeton wraps up deal for $35bn Alcentra
1 year ago
Franklin Templeton has completed its acquisition of BNY Mellon’s $35 billion credit unit Alcentra -
High yield / loan slowdown affects year-end projections and pricing: Barclays
2 years ago
A sharp decline in primary market activity means expectations for high yield bond and even leveraged loan issuance need to be lowered, say Barclays credit strategists. And that in turn has implications for relative value -
It's all relative: CLOs march tighter as macro traders open positive CDS skews
3 years ago
Credit default swaps are back near where they started the year after giving up their early-February gains amid a rise in government bonds. CDS curves steepened over the past month and macro hedging has left indices trading with positive skews. But CLOs paint a calmer picture in which spreads have inched tighter -
It's all relative: CLOs are lagging no more, as Carlyle deal drags market tighter
3 years ago
“CLOs are lagging” has been a much repeated refrain over the last nine months. But Carlyle Group has this week produced a US CLO that has dragged spreads to their tightest point in three years so that, rather than comparing CLOs to pre-covid levels, they should be assessed against early 2018 -
It's all relative: senior CLO tranches tighten 18% in Europe as CDS indices sit out rally
The corporate credit rally in January is notable because some assets tightened to levels not seen in over a decade (loans), others rallied albeit with a lag (CLOs) and the most liquid stream of credit (CDS indices) defied moves in other asset classes to widen
-
Mallinckrodt takes chapter 11 prescription as CLOs hold $650 million
3 years ago
CLO managers hold around $657.8 million debt of Mallinckrodt, a Dublin-headquartered biopharmaceutical company that has filed for chapter 11 protection in the US Bankruptcy Court for the District of Delaware -
CLOs show coronavirus resistance even as bonds and loans suffer
4 years ago
CLO managers are - so far - looking defensively positioned in relation to the coronavirus outbreak, with only two of the five largest portfolio sectors listed as very negative in latest Wells Fargo research. But investor fears have all but closed the loan and bond primary pipeline, while lower rates signalled by the US Federal Reserve could spell a fall in leveraged loan and CLO demand
7 results found Showing page 1 of 1
Want all the latest news, comment, analysis and data?